Login to Your Account



U.S. Patent Disclosures


Friday, September 27, 2013
Galectin Therapeutics Inc., of Norcross, Ga., was issued a U.S. Patent notice of issuance for 13/573,454, “Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.”

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription